ARD-501

· Aardvark Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARD-501, covering 2025-05-09 to 2025-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder [Phase 2]